
- January 2014 The Aging Population
- Volume 80
- Issue 1
Multivitamins Show No Protective Benefits Against Macular Degeneration
Although taking daily multivitamins may have some health benefits, a recent study suggests that long-term use of supplements does not reduce the risk for age-related macular degeneration.
Although taking daily multivitamins may have some health benefits, a recent study suggests that long-term use of supplements does not reduce the risk for age-related macular degeneration.
The double-blind trial assigned a total of 14,641 male physicians 50 years and older to receive a daily multivitamin or placebo for an average follow-up of 11.2 years. Participants reported cataracts and visually significant macular degeneration responsible for a reduction in best corrected visual acuity to 20/30 or worse. Self-reports were then confirmed through medical records. The results of the study were published online on November 21, 2013, in Ophthalmology.
Throughout the trial, a total of 1817 cataract cases and 281 cases of visually significant macular degeneration were reported and confirmed. The results indicated that multivitamin use significantly reduced the risk of cataracts but did nothing to decrease the risk of developing macular degeneration. Among patients who developed macular degeneration, 152 were taking multivitamins and 129 were taking a placebo.
The authors concluded that the large trial suggests that long-term, daily multivitamin supplementation does not have any protective benefits against age-related macular degeneration in middle-aged men.
Articles in this issue
almost 12 years ago
2014 Next-Generation Pharmacist Awards: Nominations Now Openalmost 12 years ago
Can You Read These Rxs?almost 12 years ago
Case Studiesalmost 12 years ago
Pet Peevesalmost 12 years ago
Generic Product Newsalmost 12 years ago
Consuming Antioxidants and Fish May Prevent Macular Degenerationalmost 12 years ago
Spacing May Improve Reading for Macular Degeneration Patientsalmost 12 years ago
Teen Boys Worry About Body Image, TooNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.













































































































































































































